Min Min Yang
Fortuna: 225 M $ al 31/07/2026
Fortuna: 225 M $ al 31/07/2026
Fundador de PharmaBlock Sciences (Nanjing), Inc., Min Min Yang es presidente de esta empresa. También forma parte del consejo de administración de Shanghai Ark Biopharmaceutical Co.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 30/09/2025 | 31.052.489 ( 99,87 % ) | 169 M $ | 31/07/2026 | |
| 30/09/2025 | 10.350.830 ( 5,47 % ) | 56 M $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| PHARMABLOCK SCIENCES (NANJING), INC. | Director Ejecutivo | 21/04/2023 |
| GEMPHARMATECH CO., LTD. | Director/Miembro de la Junta | 19/10/2023 |
Shanghai Ark Biopharmaceutical Co., Ltd.
Shanghai Ark Biopharmaceutical Co., Ltd. BiotechnologyHealth Technology Develops drugs and biopharmaceuticals for respiratory diseases | Director/Miembro de la Junta | 01/03/2021 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Auburn University
Auburn University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nanjing University
Nanjing University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shanghai Ark Biopharmaceutical Co., Ltd.
Shanghai Ark Biopharmaceutical Co., Ltd. BiotechnologyHealth Technology Develops drugs and biopharmaceuticals for respiratory diseases | Health Technology |
PharmaBlock Sciences (Nanjing), Inc.
PharmaBlock Sciences (Nanjing), Inc. Miscellaneous Commercial ServicesCommercial Services Provides technical services related to the research and development of drug molecular building blocks and process production | Commercial Services |
GemPharmatech Co., Ltd.
GemPharmatech Co., Ltd. BiotechnologyHealth Technology Specializing in the research and development of humanized models and drug screening technologies | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.